Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
Author(s) -
Abeer H. Abdelhafez,
Benjamin C. Musall,
Beatriz E. Adrada,
KennethR. Hess,
Jong Bum Son,
KenPin Hwang,
Rosalind P. Candelaria,
Lumarie Santiago,
Gary J. Whitman,
Huong LePetross,
Tanya W. Moseley,
Elsa Arribas,
Deanna L. Lane,
Marion E. Scoggins,
Jessica W. T. Leung,
Hagar S. Mahmoud,
Jason B. White,
Elizabeth E. Ravenberg,
Jennifer K. Litton,
Vicente Valero,
Peng Wei,
Alastair M. Thompson,
Stacy L. Moulder,
Mark D. Pagel,
Jingfei Ma,
Wei Yang,
Gaiane M. Rauch
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-05917-7
Subject(s) - medicine , necrosis , breast cancer , neoadjuvant therapy , magnetic resonance imaging , confidence interval , odds ratio , stage (stratigraphy) , effective diffusion coefficient , cancer , oncology , nuclear medicine , radiology , biology , paleontology
To determine if tumor necrosis by pretreatment breast MRI and its quantitative imaging characteristics are associated with response to NAST in TNBC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom